News
The patent, titled "Targeting KIT with Splice Switching Oligonucleotides to Induce Apoptosis of Mast Cells," covers the company’s approach of using splice-switching oligonucleotides to disrupt ...
Tricia Bonacker, a former program director at the Capital District Psychiatric Center, is fighting for her life as she waits ...
Seven months after the completion of dosing: 41% of patients (150 mg Q4W) continue to experience complete response (UAS7=0)48% of patients (150 mg Q4W) report that CSU no longer impacts their quality ...
Kate Beckinsale has sued the producers of “ Canary Black ,” alleging that she suffered a significant knee injury during ...
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology <l ...
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...
Kate Beckinsale has filed a lawsuit against the producers of Canary Black, claiming she suffered a serious knee injury while ...
Sanofi SA (NASDAQ:SNY) on Monday agreed to acquire Blueprint Medicines Corporation (NASDAQ:BPMC). The acquisition includes a ...
The acquisition includes a rare immunology disease medicine and an advanced and early-stage immunology pipeline.
With the deal, Sanofi gains Blueprint’s portfolio of rare immunological disease treatments, including systemic mastocytosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results